Early-stage HER2+ Breast Cancer
3 clinical trials · Condition
◉ Watch Early-stage HER2+ Breast Cancer
| Record | Firm | Date |
|---|---|---|
| An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide (NCT02400476) | Puma Biotechnology, Inc. | 2015-02-01 |
Track Early-stage HER2+ Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.